Hydrogen Energy OÜ

Active Registry code 16015469 OÜ Tartu linn Registered 23 Jul 2020
Compare

Hydrogen Energy OÜ is a OÜ based in Tartu linn, registry code 16015469, status: active. Main activity: Manufacture of medicines and other pharmaceutical preparations. Its annual report for 2025 shows revenue of €0 and 0 employees.

Revenue
0 €
Employees
0
±0 vs 2024

2025 · annual report, e-Äriregister

Position in the industry Manufacture of basic pharmaceutical products and pharmaceutical preparations · EMTAK 21

  • Revenue · 2025 0 €
    industry median 48 003 € · companies in the industry: 19

Taxes and turnover

No tax data available. EMTA publishes data for those who paid state taxes, filed a VAT return or had employees in the quarter. New and small companies may be missing.

Financials by year

2021 – 2025
Revenue, € 2025: 0 € · industry median 48 003 € · above 5% of the industry
010 00020 00030 00040 00050 0002021 Company: 0 € Industry median: 11 877 €20212022 Company: 0 € Industry median: 4 897 €20222023 Company: 0 € Industry median: 3 851 €20232024 Company: 0 € Industry median: 25 284 €20242025 Company: 0 € Industry median: 48 003 €2025010 00020 00030 00040 00050 0002021 Company: 0 € Industry median: 11 877 €20212022 Company: 0 € Industry median: 4 897 €2023 Company: 0 € Industry median: 3 851 €20232024 Company: 0 € Industry median: 25 284 €2025 Company: 0 € Industry median: 48 003 €2025
  • Company
  • Industry median

Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: 0 € · +100.0% vs 2024 · industry median 676 € · above 35% of the industry
-2 000-1 500-1 000-50005001 0002021 Company: -1 590 € Industry median: 0 €20212022 Company: 0 € Industry median: 0 €20222023 Company: 0 € Industry median: 0 €20232024 Company: -25 € Industry median: 0 €20242025 Company: 0 € Industry median: 676 €2025-2 000-1 500-1 000-50005001 0002021 Company: -1 590 € Industry median: 0 €20212022 Company: 0 € Industry median: 0 €2023 Company: 0 € Industry median: 0 €20232024 Company: -25 € Industry median: 0 €2025 Company: 0 € Industry median: 676 €2025
  • Company
  • Industry median

Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2025: 1 885 € · +0.0% vs 2024
05001 0001 5002 0002021 Company: 1 910 €20212022 Company: 1 910 €20222023 Company: 1 910 €20232024 Company: 1 885 €20242025 Company: 1 885 €202505001 0001 5002 0002021 Company: 1 910 €20212022 Company: 1 910 €2023 Company: 1 910 €20232024 Company: 1 885 €2025 Company: 1 885 €2025
Equity, € 2025: 1 885 € · +0.0% vs 2024
-2 000-1 00001 0002 0002021 Company: -1 590 €20212022 Company: -1 590 €20222023 Company: 1 910 €20232024 Company: 1 885 €20242025 Company: 1 885 €2025-2 000-1 00001 0002 0002021 Company: -1 590 €20212022 Company: -1 590 €2023 Company: 1 910 €20232024 Company: 1 885 €2025 Company: 1 885 €2025
Employees 2025: 0 · industry median 28 · above 2% of the industry
0102030402021 Company: 0 Industry median: —20212022 Company: 0 Industry median: —20222023 Company: 0 Industry median: 2520232024 Company: 0 Industry median: 3220242025 Company: 0 Industry median: 2820250102030402021 Company: 0 Industry median: —20212022 Company: 0 Industry median: —2023 Company: 0 Industry median: 2520232024 Company: 0 Industry median: 322025 Company: 0 Industry median: 282025
  • Company
  • Industry median

Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 0 0 0 1 885 1 885 0
2024 0 -25 — 1 885 1 885 0
2023 0 0 — 1 910 1 910 0
2022 0 0 — 1 910 -1 590 0
2021 0 -1 590 — 1 910 -1 590 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Return on equity (ROE)
0.0 %
Net profit / equity
Return on assets (ROA)
0.0 %
Net profit / assets
Equity ratio
100.0 %
Equity / assets
Debt ratio
0.0 %
Liabilities / assets

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 1 Jul 2026 Company’s own e-Äriregister
2024 1 Jan 2024 – 31 Dec 2024 30 Jun 2025 Company’s own e-Äriregister
2023 1 Jan 2023 – 31 Dec 2023 29 Jun 2024 Company’s own e-Äriregister
2022 1 Jan 2022 – 31 Dec 2022 26 Jun 2023 Company’s own e-Äriregister
2021 23 Jul 2020 – 31 Dec 2021 6 Jul 2022 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

  • Jaanus Pikani
    Member of a senior management body (management or supervisory board) · since 23 Jul 2020

Founders and other persons

shared board members, owners or beneficial owners

Activities (EMTAK)

  • 21201Manufacture of medicines and other pharmaceutical preparations Main
Rulings
Number, date Title Deadline State Document
Ä 50150944 / 4
3 Jul 2024
Amendment entry In force
3 Jul 2024
PDF
Ä 50150944 / 3
1 Sep 2023
Amendment entry In force
1 Sep 2023
PDF
Ä 50150944 / 2
21 Mar 2023
Amendment entry In force
21 Mar 2023
PDF
Ä 50150944
23 Jul 2020
First entry In force
23 Jul 2020
PDF

Sources: e-Äriregister and EMTA. Data updated 1 Nov 2026. Open at the source ↗ · Report an error in the data